Reuters logo
BRIEF-AnGes MG plans cooperation with Vical Inc on development of genetic medication for Chronic Hepatitis B
April 4, 2017 / 8:12 AM / 6 months ago

BRIEF-AnGes MG plans cooperation with Vical Inc on development of genetic medication for Chronic Hepatitis B

April 4 (Reuters) - AnGes MG Inc :

* Says co enters into a cooperation contract with a US-based firm Vical Incorporated, on joint development of genetic medication for treatment of Chronic Hepatitis B

Source text in Japanese: goo.gl/kNoYpP

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below